Literature DB >> 10093637

Quality-of-life information and clinical practice: the oncologist's perspective.

A Bezjak1, K M Taylor, P Ng, K Macdonald, A D DePetrillo.   

Abstract

OBJECTIVE: To collect information from a group of Canadian oncologists about their perspectives on quality of life (QOL) and QOL information.
DESIGN: A self-administered questionnaire (MD-QOL) containing 75 items with a 4-point Likert categorical response scale was administered by mail using Dillman survey methodology to all staff oncologists at a single institution.
SETTING: A large Canadian cancer care centre (Princess Margaret Hospital, Toronto). MAIN OUTCOME MEASURES: Oncologists' knowledge, attitude, current behaviour and intended willingness to use QOL information.
RESULTS: Of 67 eligible respondents 54 replied (80% response rate). In all, 74% felt that QOL can be quantified, and 95% felt that it gives information distinct from performance status measures. A total of 87% felt that published QOL data are useful for individual patient care, but 69% indicated that, at present, they would be more likely to base their recommendations on personal experience rather than on published literature. Of the respondents, 57% felt that decisions were made more difficult when QOL issues are considered.
CONCLUSIONS: The surveyed oncologists support the relevance and importance of QOL information. Data from this study were used to develop a predictive model to assess oncologists' willingness to use QOL information; the model is being tested in other studies.

Entities:  

Mesh:

Year:  1998        PMID: 10093637

Source DB:  PubMed          Journal:  Cancer Prev Control        ISSN: 1206-548X


  8 in total

1.  Oncologists' use of quality of life information: results of a survey of Eastern Cooperative Oncology Group physicians.

Authors:  A Bezjak; P Ng; R Skeel; A D Depetrillo; R Comis; K M Taylor
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  The neurology quality-of-life measurement initiative.

Authors:  David Cella; Cindy Nowinski; Amy Peterman; David Victorson; Deborah Miller; Jin-Shei Lai; Claudia Moy
Journal:  Arch Phys Med Rehabil       Date:  2011-10       Impact factor: 3.966

3.  A knowledge translation challenge: clinical use of quality of life data from cancer clinical trials.

Authors:  Michael Brundage; Brenda Bass; Ringash Jolie; Kimberley Foley
Journal:  Qual Life Res       Date:  2011-01-29       Impact factor: 4.147

4.  Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.

Authors:  David Cella; Sarah K Rosenbloom; Jennifer L Beaumont; Susan E Yount; Diane Paul; Debra Hampton; Amy P Abernethy; Paul B Jacobsen; Karen Syrjala; Jamie H Von Roenn
Journal:  J Natl Compr Canc Netw       Date:  2011-03       Impact factor: 11.908

5.  Physicians' knowledge of health-related quality of life and perception of its importance in daily clinical practice.

Authors:  Maurizio Bossola; Rita Murri; Graziano Onder; Adriana Turriziani; Massimo Fantoni; Luca Padua
Journal:  Health Qual Life Outcomes       Date:  2010-04-23       Impact factor: 3.186

6.  Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative study.

Authors:  M Brundage; A Leis; A Bezjak; D Feldman-Stewart; L Degner; K Velji; L Zetes-Zanatta; D Tu; P Ritvo; J Pater
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

7.  Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists' perspectives.

Authors:  Julie Rouette; Jane Blazeby; Madeleine King; Melanie Calvert; Yingwei Peng; Ralph M Meyer; Jolie Ringash; Melanie Walker; Michael D Brundage
Journal:  Qual Life Res       Date:  2014-11-29       Impact factor: 4.147

8.  Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).

Authors:  Susan Yount; David Cella; Donald Banik; Talat Ashraf; Daniel Shevrin
Journal:  Health Qual Life Outcomes       Date:  2003-11-21       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.